ATP5F1B
ATP synthase F(1) complex subunit beta, mitochondrial
Also known as: ATP5B, ATPB_HUMAN, ATPSB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06576
- Gene
- ATP5F1B
- Ensembl
- ENSG00000110955
- Chromosome
- 12
- Canonical length
- 529 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the beta subunit of the catalytic core. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>P06576|ATP5F1B
1 MLGFVGRVAA APASGALRRL TPSASLPPAQ LLLRAAPTAV HPVRDYAAQT SPSPKAGAAT
61 GRIVAVIGAV VDVQFDEGLP PILNALEVQG RETRLVLEVA QHLGESTVRT IAMDGTEGLV
121 RGQKVLDSGA PIKIPVGPET LGRIMNVIGE PIDERGPIKT KQFAPIHAEA PEFMEMSVEQ
181 EILVTGIKVV DLLAPYAKGG KIGLFGGAGV GKTVLIMELI NNVAKAHGGY SVFAGVGERT
241 REGNDLYHEM IESGVINLKD ATSKVALVYG QMNEPPGARA RVALTGLTVA EYFRDQEGQD
301 VLLFIDNIFR FTQAGSEVSA LLGRIPSAVG YQPTLATDMG TMQERITTTK KGSITSVQAI
361 YVPADDLTDP APATTFAHLD ATTVLSRAIA ELGIYPAVDP LDSTSRIMDP NIVGSEHYDV
421 ARGVQKILQD YKSLQDIIAI LGMDELSEED KLTVSRARKI QRFLSQPFQV AEVFTGHMGK
481 LVPLKETIKG FQQILAGEYD HLPEQAFYMV GPIEEAVAKA DKLAEEHSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5F1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 2,993 nTPM
Expression across tissuesHPA
Tissue
- tongue: 2,993 nTPM
- skeletal muscle: 2,427 nTPM
- heart muscle: 2,013 nTPM
- parathyroid gland: 1,231 nTPM
- choroid plexus: 893 nTPM
- kidney: 883 nTPM
Single-cell type
- syncytiotrophoblasts: 1,351 nCPM
- parietal cells: 1,278 nCPM
- esophageal basal cells: 1,128 nCPM
- esophageal suprabasal cells: 1,098 nCPM
- cytotrophoblasts: 975 nCPM
- enteric transient amplifying cells: 955 nCPM
Immune cell
- total PBMC: 1,076 nTPM
- non-classical monocyte: 754 nTPM
- myeloid DC: 714 nTPM
- intermediate monocyte: 644 nTPM
- classical monocyte: 550 nTPM
- basophil: 404 nTPM
Brain region
- choroid plexus: 765 nTPM
- hypothalamus: 472 nTPM
- cerebral cortex: 452 nTPM
- cerebellum: 417 nTPM
- pons: 412 nTPM
- thalamus: 406 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5F1B.
Disease | AllUniProt
Conditions ATP5F1B is implicated in, by any mechanism.
- Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 (HUMOP2) MIM:620085
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 61 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2
- Hypermetabolism due to Defect in Mitochondrial Coupling
Disease | ImmuneIEDB
Conditions an epitope on ATP5F1B was assayed in.
- allergic disease T cell
- Chagas disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- DepMap mean gene effect
- -0.93
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- ATP biosynthetic process
- cellular response to interleukin-7
- generation of precursor metabolites and energy
- lipid metabolic process
- negative regulation of cell adhesion involved in substrate-bound cell migration
- osteoblast differentiation
- positive regulation of blood vessel endothelial cell migration
- proton motive force-driven ATP synthesis
- proton motive force-driven mitochondrial ATP synthesis
- proton transmembrane transport
- regulation of intracellular pH
Molecular functions
- angiostatin binding
- ATP binding
- metal ion binding
- MHC class I protein binding
- proton-transporting ATP synthase activity, rotational mechanism
- proton-transporting ATPase activity, rotational mechanism
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain
- AAA+ ATPase domain
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain
- ATPase, alpha/beta subunit, nucleotide-binding domain, active site
- ATPase, F1/V1 complex, beta/alpha subunit, C-terminal
- P-loop containing nucleoside triphosphate hydrolase
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain superfamily
- ATP synthase A/B type, C-terminal domain
- ATP synthase alpha/beta family, nucleotide-binding domain
- ATP synthase alpha/beta family, beta-barrel domain
- C-terminal domain of V and A type ATP synthase
- ATP synthase, F1 complex, beta subunit
- ATPase alpha/beta chains
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5F1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5F1B as an antibody target. Whether an autoantibody or antibody against ATP5F1B could matter depends on whether native ATP5F1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5F1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5F1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...